Ascendis Pharma A/S Finance Costs
Ascendis Pharma A/S (ASND) reported Finance Costs of EUR 206.69 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-02-11
- Ascendis Pharma A/S finance costs for the quarter ending 2025-12-31 was 61.98M EUR, a 109.82% increase year-over-year.
- Ascendis Pharma A/S finance costs for the quarter ending 2025-09-30 was 66.90M EUR, a 163.95% increase year-over-year.
- Ascendis Pharma A/S finance costs for the quarter ending 2025-06-30 was 33.02M EUR, a 68.25% increase year-over-year.
- Ascendis Pharma A/S finance costs for the quarter ending 2025-03-31 was 44.79M EUR, a 41.96% decline year-over-year.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 9 month | Finance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | 61.98M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 128.88M EUR derived: sum of 2 quarters · filed 2026-02-11 | 161.90M EUR derived: sum of 3 quarters · filed 2026-02-11 | 206.69M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 66.90M EUR 6-K · filed 2025-11-12 | 99.92M EUR derived: sum of 2 quarters · filed 2025-11-12 | 144.71M EUR 6-K · filed 2025-11-12 | 174.25M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 33.02M EUR 6-K · filed 2025-08-07 | 77.80M EUR 6-K · filed 2025-08-07 | 107.34M EUR derived: sum of 3 quarters · filed 2026-02-11 | 132.69M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 44.79M EUR 6-K · filed 2025-05-01 | 74.33M EUR derived: sum of 2 quarters · filed 2026-02-11 | 99.67M EUR derived: sum of 3 quarters · filed 2026-02-11 | 119.30M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 29.54M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 54.89M EUR derived: sum of 2 quarters · filed 2026-02-11 | 74.51M EUR derived: sum of 3 quarters · filed 2026-02-11 | 100.03M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 25.35M EUR 6-K · filed 2025-11-12 | 44.97M EUR derived: sum of 2 quarters · filed 2025-11-12 | 70.49M EUR 6-K · filed 2025-11-12 | 130.56M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 19.62M EUR 6-K · filed 2025-08-07 | 58.55M EUR 6-K · filed 2025-08-07 | 105.21M EUR derived: sum of 3 quarters · filed 2026-02-11 | 129.73M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 77.16M EUR 6-K · filed 2025-05-01 | 85.59M EUR derived: sum of 2 quarters · filed 2026-02-11 | 110.11M EUR derived: sum of 3 quarters · filed 2026-02-11 | 119.44M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 8.43M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 32.94M EUR derived: sum of 2 quarters · filed 2026-02-11 | 42.28M EUR derived: sum of 3 quarters · filed 2026-02-11 | 44.06M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 24.52M EUR 6-K · filed 2024-11-14 | 33.85M EUR derived: sum of 2 quarters · filed 2024-11-14 | 35.64M EUR 6-K · filed 2024-11-14 | 68.80M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 9.33M EUR 6-K · filed 2024-09-03 | 18.65M EUR 6-K · filed 2024-09-03 | 44.28M EUR derived: sum of 3 quarters · filed 2025-02-12 | 85.53M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 9.84M EUR 6-K · filed 2024-05-02 | 34.95M EUR derived: sum of 2 quarters · filed 2025-02-12 | 76.19M EUR derived: sum of 3 quarters · filed 2025-02-12 | 85.63M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 25.11M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 66.35M EUR derived: sum of 2 quarters · filed 2025-02-12 | 75.79M EUR derived: sum of 3 quarters · filed 2025-02-12 | 50.49M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 41.25M EUR 6-K · filed 2023-11-07 | 50.68M EUR derived: sum of 2 quarters · filed 2023-11-07 | 25.38M EUR 6-K · filed 2023-11-07 | 57.41M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 9.43M EUR 6-K · filed 2023-09-05 | 14.83M EUR 6-K · filed 2023-09-05 | 16.16M EUR derived: sum of 3 quarters · filed 2024-02-07 | 17.04M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 5.40M EUR 6-K · filed 2023-04-27 | 6.73M EUR derived: sum of 2 quarters · filed 2024-02-07 | 7.61M EUR derived: sum of 3 quarters · filed 2024-02-07 | 19.75M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 1.33M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 2.21M EUR derived: sum of 2 quarters · filed 2024-02-07 | 14.35M EUR derived: sum of 3 quarters · filed 2024-02-07 | 3.91M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 877.00K EUR 6-K · filed 2022-11-02 | 13.02M EUR derived: sum of 2 quarters · filed 2022-11-02 | 2.58M EUR 6-K · filed 2022-11-02 | 54.34M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 12.14M EUR 6-K · filed 2022-08-10 | 1.70M EUR 6-K · filed 2022-08-10 | 53.46M EUR derived: sum of 3 quarters · filed 2023-02-16 | 93.43M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 869.00K EUR 6-K · filed 2022-05-11 | 41.32M EUR derived: sum of 2 quarters · filed 2023-02-16 | 81.29M EUR derived: sum of 3 quarters · filed 2023-02-16 | 91.58M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 40.45M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 80.42M EUR derived: sum of 2 quarters · filed 2023-02-16 | 90.71M EUR derived: sum of 3 quarters · filed 2023-02-16 | 80.84M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 39.97M EUR 6-K · filed 2021-11-10 | 50.26M EUR derived: sum of 2 quarters · filed 2021-11-10 | 40.39M EUR 6-K · filed 2021-11-10 | 51.12M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 10.29M EUR 6-K · filed 2021-08-27 | 876.00K EUR 6-K · filed 2021-08-27 | 11.15M EUR derived: sum of 3 quarters · filed 2022-03-02 | 11.52M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 447.00K EUR 6-K · filed 2021-05-27 | 856.00K EUR derived: sum of 2 quarters · filed 2022-03-02 | 1.22M EUR derived: sum of 3 quarters · filed 2022-03-02 | 9.72M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 409.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 777.00K EUR derived: sum of 2 quarters · filed 2022-03-02 | 9.27M EUR derived: sum of 3 quarters · filed 2022-03-02 | 1.22M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 368.00K EUR 6-K · filed 2020-11-12 | 8.86M EUR derived: sum of 2 quarters · filed 2020-11-12 | 812.00K EUR 6-K · filed 2020-11-12 | 9.13M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 8.49M EUR 6-K · filed 2020-08-27 | 5.62M EUR 6-K · filed 2020-08-27 | 8.76M EUR derived: sum of 3 quarters · filed 2021-03-10 | 8.80M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 194.00K EUR 6-K · filed 2020-05-19 | 268.00K EUR derived: sum of 2 quarters · filed 2021-03-10 | 310.00K EUR derived: sum of 3 quarters · filed 2021-03-10 | 316.00K EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 74.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 116.00K EUR derived: sum of 2 quarters · filed 2021-03-10 | 122.00K EUR derived: sum of 3 quarters · filed 2021-03-10 | 127.00K EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 42.00K EUR 6-K · filed 2019-11-18 | 48.00K EUR derived: sum of 2 quarters · filed 2019-11-18 | 53.00K EUR 6-K · filed 2019-11-18 | 10.05M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 6.00K EUR 6-K · filed 2019-08-28 | 11.00K EUR 6-K · filed 2019-08-28 | 10.01M EUR derived: sum of 3 quarters · filed 2020-04-03 | 12.82M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 7.01M EUR 6-K · filed 2019-05-30 | 10.00M EUR derived: sum of 2 quarters · filed 2020-04-03 | 12.81M EUR derived: sum of 3 quarters · filed 2020-04-03 | 19.04M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 2.99M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 5.80M EUR derived: sum of 2 quarters · filed 2020-04-03 | 12.03M EUR derived: sum of 3 quarters · filed 2020-04-03 | 13.76M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 2.81M EUR 6-K · filed 2018-11-28 | 9.04M EUR derived: sum of 2 quarters · filed 2018-11-28 | 10.77M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 6.23M EUR 6-K · filed 2018-08-29 | 7.96M EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 1.72M EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 3.11M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 2.80M EUR 20-F · filed 2018-03-28 |